Related Experiment Video
Updated: May 29, 2025

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Advancing Diabetes Equity through Health Policy Advocacy
1Director, Advanced Center for Diabetes, Thyroid and Obesity, Noida, Uttar Pradesh, India, Orcid: https://orcid.org/0000-0002-9632-4194, Corresponding Author.
Abstract:
As per International Diabetes Federation estimates, the world diabetic population is expected to reach 643 million by 2030 and 783 million by 2045.1 The global rise in diabetes cases has underscored the urgent need to address the inequities that persist in diabetes care. As per the World Health Organization, "health equity" has been defined as "the absence of unfair, avoidable, or remediable differences among groups of people, whether those groups are defined socially, economically, demographically, geographically, or by other dimensions of inequality (e.g., sex, gender, ethnicity, disability, or sexual orientation)."2.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Standards of Care II

